「クリア」とはどういう意味ですか？
その動物は突然変異を持っていません。病気を発症することはありません そしてそれを伝えません。
馬 小脳の萎縮症 (CA)
Cerebellar Abiotrophy (CA) is a genetic disorder affecting horses, leading to progressive loss of coordination and balance. A DNA test for CA helps identify carriers and affected horses, enabling breeders to make informed decisions and reduce the risk of passing this debilitating condition to offspring. Early detection through genetic testing is crucial for managing breeding programs and maintaining healthy equine populations. This test is especially important for breeds prone to CA, such as Arabian horses. By using the CA DNA test, owners can ensure better care and improve the overall welfare of their horses. Stay proactive and protect your equine investment with reliable genetic screening for Cerebellar Abiotrophy.
略語 ： CA
解析された変異: MUTYH c.541-13539C/T
継承 ： 常染色体劣性
頭字語
CA
観測周波数
臨床的重症度
臨床分類
神経疾患
解析された変異
MUTYH c.541-13539C/T
継承のモード
常染色体劣性 （完了）
テストの概要:
Cerebellar Abiotrophy (CA) is a genetic disorder in horses that affects the cerebellum, leading to coordination and balance issues. A DNA test can identify carriers and affected horses by detecting the specific mutation responsible for CA. This test helps breeders make informed decisions to avoid producing affected foals. Early diagnosis through DNA testing improves management and care for affected horses. Overall, the CA DNA test is a valuable tool for promoting healthier breeding practices.
パックから入手可能: Basic
この DNA 検査はパックから含まれています Basic — これもパックの一部です Basic, Standard, Advanced, Complete。
DNA テスト パックを見る →動物の繁殖戦略や健康戦略に最適なパックをお選びください。
Understanding Cerebellar Abiotrophy (CA) in Horses
Cerebellar Abiotrophy (CA) is a neurological condition observed in horses, characterized by the degeneration of the cerebellum, a part of the brain responsible for coordination and balance. This condition typically manifests in young horses, often between the ages of 6 months and 3 years, leading to significant motor dysfunction. Affected horses may exhibit symptoms such as incoordination, difficulty standing, and abnormal gait, which can severely impact their quality of life and training potential.
Genetic Basis of Cerebellar Abiotrophy
CA is recognized as a hereditary disorder, often associated with specific genetic mutations. The condition arises due to the improper development and subsequent degeneration of Purkinje cells within the cerebellum. These cells play a crucial role in motor control, and their loss leads to the clinical signs observed in affected individuals. Understanding the genetic underpinnings of CA has paved the way for DNA testing, which can identify carriers and help breeders make informed decisions.
Clinical Signs of Cerebellar Abiotrophy
The clinical signs of CA can vary in severity but generally include a range of neurological deficits. Common symptoms include a lack of coordination, especially in the hind limbs, a wide-based stance, and difficulty with balance. Affected horses may also show signs of intention tremors, where they exhibit tremors when trying to perform tasks such as eating or drinking. These symptoms can significantly hinder the horse's ability to engage in routine activities and can lead to frustration for both the animal and its handler.
Diagnosis of Cerebellar Abiotrophy
Diagnosing CA typically involves a combination of clinical evaluation and genetic testing. Veterinarians assess the horse's neurological function and may perform additional tests to rule out other conditions that could cause similar symptoms. Genetic testing plays a crucial role in confirming the diagnosis and understanding the horse's genetic predisposition to the condition.
Management and Prognosis
Currently, there is no cure for Cerebellar Abiotrophy, and management focuses on supportive care and ensuring the horse's safety. Affected horses may require specialized handling and training approaches to accommodate their coordination issues. The prognosis for horses with CA varies; some may lead relatively normal lives with adaptations, while others may need to be retired from work due to the severity of their symptoms.
結論
Cerebellar Abiotrophy is a significant concern in equine health, particularly due to its genetic nature and impact on horse performance and welfare. DNA testing serves as a valuable tool for breeders and owners, providing insights into the likelihood of developing this condition. Increased awareness and understanding of CA are essential for effective management and the continued health of affected horses.
試験に認められた品種: 小脳の萎縮症 (CA)
- Arab
- Bashkir Curly
- Quarter Horse
- Trakehner
- Welsh Pony
🧬 Interpretation of genotypes CA
遺伝子型
状態
🟡 N/N
ノンキャリア - リスクなし
🟡 N/CA
キャリア - リスクなし
❌ CA/CA
影響を受ける – 危険にさらされる
FAQ: 解釈を理解する
「キャリア」って本気なの？
いいえ、その動物は通常健康ですが、突然変異をその動物に伝える可能性があります。 子孫。
動物が「影響を受けている」場合はどうなりますか?
それは2つの突然変異したコピーを持っています。臨床症状は以下に応じて予想されます 病気。飼育してはいけません。
なぜ男性/女性で違いがあるのでしょうか？
一部の病気は性と関連があるため、その発現は性別によって異なります。 動物の性別。
子孫を予測する
N/N (%e3%83%8e%e3%83%b3%e3%82%ad%e3%83%a3%e3%83%aa%e3%82%a2）
N/CA (キャリア）
CA/CA (影響を受ける）
DNA検査に関するよくある質問
この DNA 検査では何が検出されますか?
This DNA test detects the mutation associated with Cerebellar Abiotrophy (CA) in order to identify clear, carrier, or at-risk animals.
なぜ繁殖動物を検査するのでしょうか?
DNA検査は、ブリーダーがより安全な交配を計画し、子孫に突然変異が伝わるリスクを軽減するのに役立ちます。
このテストの継承モードは何ですか?
このテストで報告される継承モードは常染色体劣性です。
このテストではどの変異が分析されますか?
This test analyses the mutation MUTYH c.541-13539C/T.
保菌動物は必ず影響を受けますか?
必ずしもそうとは限りません。解釈は、遺伝パターンと結果として生じる遺伝子型によって異なります。
参考文献
Brault Leah S, Cooper Caitlin A, Famula Thomas R, Murray James D, Penedo M Cecilia T. Mapping of equine cerebellar abiotrophy to ECA2 and identification of a potential causative mutation affecting expression of MUTYH. Genomics. 2011 Feb;97(2):121-9. doi: 10.1016/j.ygeno.2010.11.006. Epub 2010 Nov 30.